CureVac starts Phase 1 trials for Omicron-specific vaccine
CureVac has started the Phase 1 clinical study for its modified COVID-19 mRNA vaccine candidate CV0501: intended to be administered as a booster dose.
Archives for August 22, 2022
Bavarian Nordic engages US contract manufacturer to increase smallpox/monkeypox vaccine capacity
Bavarian Nordic has entered into an agreement with Grand River Aseptic Manufacturing (GRAM), a US based contract manufacturer, for fill and finish of the Jynneos smallpox/monkeypox vaccine in the country.
DNA plasmid manufacturer’s new Texas site has ‘greatly expanded’ capabilities
VGXI, a contract developer and manufacturer (CDMO), says its new headquarters and manufacturing facility in Texas is slated to open in the fall.
EMA evaluating Skycovion COVID-19 vaccine
EMA has begun its review of the conditional marketing authorization application from South Korean developer, SK biosciences, for its COVID-19 vaccine, Skycovion, a recombinant protein-based vaccine with adjuvant from GSK.